Page last updated: 2024-09-02

fingolimod hydrochloride and erythrosine

fingolimod hydrochloride has been researched along with erythrosine in 2 studies

Compound Research Comparison

Studies (fingolimod hydrochloride)	Trials (fingolimod hydrochloride)	Recent Studies (post-2010) (fingolimod hydrochloride)	Studies (erythrosine)	Trials (erythrosine)	Recent Studies (post-2010) (erythrosine)
2,771	157	2,062	15,483	108	2,574

Protein Interaction Comparison

Protein	Taxonomy	fingolimod hydrochloride (IC50)	erythrosine (IC50)
Genome polyprotein	Zika virus		1.7
large T antigen	Betapolyomavirus macacae		13.04

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Forrest, MJ; Koprak, SL; Nomura, N; Quackenbush, EJ; Rosen, H; Xie, JH	1
Asahi, M; Culp, C; Foos, WF; Patronas, M	1

Other Studies

2 other study(ies) available for fingolimod hydrochloride and erythrosine

Article	Year
Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. Journal of immunology (Baltimore, Md. : 1950), 2003, Apr-01, Volume: 170, Issue:7 Topics: Animals; Antigens; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Epitopes, T-Lymphocyte; Fingolimod Hydrochloride; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Growth Inhibitors; Immunosuppressive Agents; Injections, Subcutaneous; Interphase; Lymph Nodes; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Ovalbumin; Propylene Glycols; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine; Succinimides; Th1 Cells	2003
Siponimod-related bilateral cystoid macular oedema and intravenous fluorescein angiographic findings in a patient with stable proliferative diabetic retinopathy without history of diabetic macular oedema. BMJ case reports, 2022, Nov-11, Volume: 15, Issue:11 Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Edema; Visual Acuity	2022

Article

Year

Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells.

Journal of immunology (Baltimore, Md. : 1950), 2003, Apr-01, Volume: 170, Issue:7

Topics: Animals; Antigens; Bromodeoxyuridine; CD4-Positive T-Lymphocytes; Cell Division; Cell Movement; Epitopes, T-Lymphocyte; Fingolimod Hydrochloride; Flow Cytometry; Fluoresceins; Fluorescent Dyes; Growth Inhibitors; Immunosuppressive Agents; Injections, Subcutaneous; Interphase; Lymph Nodes; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocyte Depletion; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Transgenic; Ovalbumin; Propylene Glycols; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Lysophospholipid; Sphingosine; Succinimides; Th1 Cells

2003

BMJ case reports, 2022, Nov-11, Volume: 15, Issue:11

Topics: Diabetes Mellitus; Diabetic Retinopathy; Fingolimod Hydrochloride; Fluoresceins; Humans; Macular Edema; Visual Acuity

2022